Allergies News and Research

Latest Allergies News and Research

COVID-19 study: Researchers recruit frontline workers to identify asymptomatic individuals

Fifteen hundred frontline workers are being recruited for a yearlong study to find what percentage are positive for the virus that causes COVID-19, what percentage become positive and whether the antibodies they produce protect them from reinfection.

30 Oct 2020

UH and CWRU announce Phase 3 trial of Astrazeneca's investigational COVID-19 vaccine

University Hospitals and Case Western Reserve University announced today that UH Cleveland Medical Center has been selected as a clinical trial site for the Phase 3 global study of an investigational vaccine against SARS-CoV-2, sponsored by AstraZeneca.

29 Oct 2020

Research shows why certain people infected with COVID-19 show no symptoms

Researchers worldwide have been surprised to see that individuals can be infected with the SARS-CoV-2 virus - the virus that produces COVID-19 - without showing symptoms. Since these individuals expose others to infection without knowing it, it is important to find an explanation and hopefully a solution to this.

29 Oct 2020

Majority of people infected with mild-to-moderate COVID 19 mount robust antibody response

The vast majority of individuals infected with mild-to-moderate COVID 19 mount a robust antibody response that is relatively stable for at least five months, according to research conducted at the Icahn School of Medicine at Mount Sinai and published October 28, in the journal Science.

29 Oct 2020

Study reveals human protein that helps the immune system fight viral infections

University of North Carolina School of Medicine scientists has made a curious discovery about a well-known human protein that helps the immune system fight viral infections.

27 Oct 2020

Scientists devise new method to map HIV's sugary shield in unprecedented detail

Scientists from Scripps Research and Los Alamos National Laboratory have devised a method for mapping in unprecedented detail the thickets of slippery sugar molecules that help shield HIV from the immune system.

23 Oct 2020

Preventive antimalarial treatments drastically reduce malaria infections among school children

With nearly half of the world's population at risk for life-threatening malaria infections, University of Maryland School of Medicine (UMSOM) researchers and their colleagues identified an important public health measure to control the disease.

23 Oct 2020

New therapeutic approach for treating patients with compromised immune systems

A young woman who had been hospitalized for three months straight due to debilitating, recurrent infections with no apparent underlying cause was finally able to go home thanks to a Massachusetts General Hospital (MGH) team who put their heads together, discovered a root of the problem, and developed a novel treatment strategy just for her.

23 Oct 2020

New research may shed light on challenges of developing universal flu vaccine

New research from an immunology team at the University of Chicago may shed light on the challenges of developing a universal flu vaccine that would provide long-lasting and broad protection against influenza viruses.

23 Oct 2020

$2 million NCI SeroNet grant aims to increase diversity in COVID-19 immunology research

A new, $2 million grant from the NCI Serological Sciences Network for COVID-19 (SeroNet) is aimed at enhancing representation of Black and Hispanic people in SARS-CoV-2 immunology research through the use of storytelling--an approach in which community members become "video stars" and provide honest messages about the importance of being represented in COVID-19 research studies.

22 Oct 2020

Study reveals developmental changes of the immune system during first week of life

Within the womb, a human fetus benefits from the protection of the placenta, limiting their contact with pathogens.

22 Oct 2020

First antiviral treatment for COVID-19 receives FDA approval

Today, the U.S. Food and Drug Administration approved the antiviral drug Veklury (remdesivir) for use in adult and pediatric patients 12 years of age and older and weighing at least 40 kilograms (about 88 pounds) for the treatment of COVID-19 requiring hospitalization.

22 Oct 2020

Allergy charities encourage parents, teachers to ‘Check It, Don’t Chance It’ to safeguard allergic children

To mark Allergy Awareness Week (19-25 October), two leading allergy charities are urging parents and teachers to ‘Check It, Don’t Chance It’ to ensure pupils and young adults with allergies are safe in schools.

21 Oct 2020

Increasing levels of light pollution could impact transmission of diseases through mosquitoes

Artificial light abnormally increases mosquito biting behavior at night in a species that typically prefers to bite people during the day, according to research from the University of Notre Dame that was published in The American Journal of Tropical Medicine and Hygiene.

21 Oct 2020

Exploring the role of insects as potential new food allergen

Those with food allergies must avoid allergens in food. Health problems can be triggered by even the smallest traces for those affected.

20 Oct 2020

Psoriasis patients taking immunosuppressants have high COVID-19 survival rates

Patients with psoriasis who are taking drugs that affect their immune system have high rates of survival from COVID-19. According to the first findings from a global registry of psoriasis and COVID-19 patients, led by Guy's and St Thomas' clinicians, over 90% survive.

20 Oct 2020

Researchers identify potential drugs that could be repurposed as pan-coronavirus treatments

A large international consortium of almost 200 researchers from 14 leading institutions in six countries has studied three different coronaviruses - SARS-CoV-1, SARS-CoV-2, and MERS-CoV - with the aim of finding vulnerabilities shared by these three pathogens.

15 Oct 2020

Allergies News and Research

Latest Allergies News and Research

COVID-19 study: Researchers recruit frontline workers to identify asymptomatic individuals

UH and CWRU announce Phase 3 trial of Astrazeneca's investigational COVID-19 vaccine

Research shows why certain people infected with COVID-19 show no symptoms

Majority of people infected with mild-to-moderate COVID 19 mount robust antibody response

Study reveals human protein that helps the immune system fight viral infections

Scientists devise new method to map HIV's sugary shield in unprecedented detail

Preventive antimalarial treatments drastically reduce malaria infections among school children

New therapeutic approach for treating patients with compromised immune systems

New research may shed light on challenges of developing universal flu vaccine

$2 million NCI SeroNet grant aims to increase diversity in COVID-19 immunology research

Study reveals developmental changes of the immune system during first week of life

First antiviral treatment for COVID-19 receives FDA approval

Allergy charities encourage parents, teachers to ‘Check It, Don’t Chance It’ to safeguard allergic children

Increasing levels of light pollution could impact transmission of diseases through mosquitoes

Exploring the role of insects as potential new food allergen

Psoriasis patients taking immunosuppressants have high COVID-19 survival rates

Researchers identify potential drugs that could be repurposed as pan-coronavirus treatments

Cloud-based tool can rapidly detect and track emerging pathogens

GIV protein involved in the immune system could form basis for novel therapeutics

Certain live-attenuated vaccines can prevent severe complications of COVID-19

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Allergies News and Research

Latest Allergies News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in